Cyclooxygenase-2 signaling in vocal fold fibroblasts

Laryngoscope

Volumn 120, Issue 9, 2010, Pages 1826-1831

  Branski, Ryan C ^a   Zhou, Hang ^a,b   Sandulache, Vlad C ^c   Chen, Jie ^b   Felsen, Diane ^b   Kraus, Dennis H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Baylor College of Medicine   (United States)

Author keywords

Cyclooxygenase; Inflammation; NF B; Prostaglandin; Vocal fold

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN P50; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN P65; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FIBROBLAST; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEADY STATE; VOCAL CORD; WESTERN BLOTTING; WOUND HEALING;

ACTIVE TRANSPORT, CELL NUCLEUS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; NF-KAPPA B; RECEPTORS, PROSTAGLANDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VOCAL CORDS;

EID: 77956604027     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21017     Document Type: Article

References (41)

1. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996;115;474-482.
2. Futagami A, Ishizaki M, Fukuda Y, Kawana S, Yamanaka N. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest 2002;82:1503-1513.
3. Wilgus TA, Bergdall VK, Tober KL, et al. The impact of cyclooxygenase-2 mediated inflammation on scarless wound healing. Am J Pathol 2004;165:753-761.
4. Branski R, Rosen C, Verdolini K, Hebda P. Biochemical markers associated with acute vocal fold wound healing: a rabbit model. J Voice 2005;19:283-289.
5. Verdolini K, Rosen C, Branski R, Hebda P. Shifts in biochemical markers associated with wound healing in laryngeal secretions following phonotrauma: a preliminary study. Ann Otol Rhinol Laryngol 2003;112:1021-1025.
6. Karahan N, Baspinar S, Yariktas M, Kapucuoglu N. Matrix metalloproteinases (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) expressions in vocal cord polyps. J Voice 2009;23:29-33.
7. Noguchi K, Iwasaki K, Shitashige M, et al. Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts. Inflammation 2001;25:75-81.
8. Noguchi K, Iwasaki K, Shitashige M, Ishikawa I. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts. J Periodontal Res 1999;34:478-485.
9. Kohyama T, Ertl RF, Valenti V, et al. Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 2001;281:L1257-L1263.
10. Choung J, Taylor L. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type 1 collagen alpha 1, lysyl hydroxylase, and cyclooxygenase-1 genes in human embryo lung fibroblasts. J Cell Biochem 1998;71:254-263.
11. Schmitz T, Dallot E, Leroy MJ, Breuiller-Fouche M, Ferre F, Cabrol D. EP(4) receptors mediate prostaglandin E(2)-stimulated glycosaminoglycan synthesis in human cervical fibroblasts in culture. Mol Hum Reprod 2001;7:397-402.
12. Kanekura T, Higashi Y, Kazaki T. Cyclooxygenase-2 expression and prostaglandin E2 biosynthesis are enhanced in scleroderma fibroblasts and inhibited by UVA irradiation. J Rheumatol 2001;28:1568-1572.
13. Vancheri C, Sortino MA, Tomaselli V, et al. Different expression of TNF-alpha receptors and prostaglandin E(2) production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 2000;22:628-634.
14. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995;95:1861-1865.
15. Adzick NS, Longaker MT. Scarless fetal healing. Therapeutic implications. Ann Surg 1992;215:3-7.
16. Szpaderska AM, Zuckerman JD, DiPietro LA. Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 2003;82:621-626.
17. Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 2007;127:1009-1017.
18. Martin P, D'Souza D, Martin J, et al. Wound healing in the PU.1 null mouse - tissue repair is not dependent on inflammatory cells. Curr Biol 2003;1:1122-1128.
19. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004;24:40-46.
20. Keerthisingam CB, Jenkins RG, Harrison NK, et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001;158:1411-1422.
21. Naraba H, Yokoyama C, Tago N, et al. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 2002;277:28601-28608.
22. Abramovitz M, Adam M, Boie Y, et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochem Biophys Acta 2000;1483:285-293.
23. Desai S, April H, Nwaneshiudu C, Ashby B. Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration. Mol Pharmacol 2000;58:1279-1286.
24. Bhattacharya M, Peri K, Ribeiro-da-Silva A, et al. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 1999;274:15719-15724.
25. Breyer MD, Breyer RM. Prostaglandin receptors: their role in regulating renal function. Curr Opin Nephrol Hypertens 2000;9:23-29.
26. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193-1226.
27. Nasrallah R, Zimpelmann J, Singh S, Hebert RL. Molecular and biochemical characterization of prostacyclin receptors in rat kidney. Am J Physiol Renal Physiol 2001;280:F266-F277.
28. Ivano, AI, Scheck AC, Romanovsky AA. Expression of genes controlling transport and catabolism of prostaglandin E2 in lipopolysaccharid fever. Am J Physiol Regul Integr Comp Physiol 2003;284:R698-R706.
29. Wan F, Lendardo MJ. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res 2010;20:24-33.
30. Branski RC, Barbieri SS, Weksler BB, et al. Effects of transforming growth factor-beta1 on human vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2009;118:218-226.
31. Welham NV, Lim X, Tateya I, Bless DM. Inflammatory factor profiles one hour following vocal fold injury. Ann Otol Rhinol Laryngol 2008;117:145-152.
32. Planaguma A, Claria J, Miquel R, et al. The selective cyclooxygenase- 2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPAR-gamma activation. FASEB J 2005;19:1120-1122.
33. Kucuk HF, Bingul SM, Kurt N, et al. Effect of a selective cyclooxygenase-2 inhibitor on renal scarring. Eur Surg Res 2006;38:451-457.
34. Sciarra A, Salciccia S, Albanesi L, Cardi A, D'Eramo G, Di Silverio F. Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate. Urology 2005;66:1218-1222.
35. LaPointe MC, Mendez M, Leung A, Tao Z, Yang XP. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 2004;286:H1416-H1424. (Pubitemid 38381150)
36. Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Rep Reg 2003;11:25-34.
37. Branski RC, Rosen CA, Verdolini K, Hebda PA. Acute vocal fold wound healing in a rabbit model. Ann Otol Rhinol Laryngol 2005;114:19-24.
38. Branski RC, Verdolin, K, Rosen CA, Hebda PA. Markers of wound healing in vocal fold secretions from patients with laryngeal pathology. Ann Otol Rhinol Laryngol 2004;113:23-29.
39. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004;18:2195-2224.
40. Schmedtje JF, Ji YS, Liu WL, Dubois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997;272:601-608.
41. Stuhlmeier KM, Broll J, Iliev B. NF-kappaB independent activation of a series of proinflammatory genes by hydrogen sulfide. Exp Biol Med 2009;234:1327-1338.